Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous Lymphoma

Clinical trial NCT01556035 · COMPLETED

Trial details

NCT number

NCT01556035

Sponsor

University Hospital, Bordeaux

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2012-07-01

Primary completion

2015-03-01

Enrollment

19

View on ClinicalTrials.gov